Retinal changes after fluocinolone acetonide implant (ILUVIEN®) for DME: SD-OCT imaging assessment using ESASO classification.
João LeiteAndré S FerreiraCatarina Saragoça CastroJoão CoelhoTânia BorgesNuno CorreiaBernardete PessoaPublished in: European journal of ophthalmology (2023)
In persistent or recurrent DME, fluocinolone acetonide implantation can be effective in improving maculopathy stage and reducing the percentage of eyes with: intraretinal cysts; CFT > 30% above the upper normal value; and disrupted or absent EZ and/or ELM. It can also increase BCVA and reduce CFT.